Hypertensive intracerebral hemorrhage
Conditions
Interventions
Study group:Provide patients with a blood pressure monitoring form. Continuously monitoring blood pressure for 90 days starting from treatment, three times a day.
Control group:No blood pressure monitoring form. Continuously monitoring blood pressure for 7 days and days 15, 30, 60, and 90starting from treatment, three times a day.
Sponsors
Zhangjiakou First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: A patient who has initially developed a disease and is diagnosed with hypertensive intracerebral hemorrhage, has not undergone regular diagnosis and treatment in an external hospital, is over 18 years old, and has signed an informed consent form.
Exclusion criteria
Exclusion criteria: Patients with intracranial aneurysms, intracranial arteriovenous malformations, moyamoya disease, and other cerebrovascular diseases; Suffering from coagulation disorders and related diseases of the blood system; Severe heart, liver, or kidney disease; Have a history of malignant tumors; Report women who are pregnant or breastfeeding; Patients or family members are unable to use electronic blood pressure meters correctly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure; | — |
Countries
China
Contacts
Public ContactYuan Hou
Zhangjiakou First Hospital
Outcome results
None listed